FINWIRES · TerminalLIVE
FINWIRES

Rothschild & Co Redburn Adjusts Biogen Price Target to $180 From $150, Maintains Neutral Rating

-- Biogen (BIIB) has an average rating of overweight and mean price target of $213.07, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $191.67, Change: $+5.72, Percent Change: +3.07%

相关文章